These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7741988)

  • 1. The second generation CA 125 assays.
    Kenemans P; Verstraeten AA; van Kamp GJ; von Mensdorff-Pouilly S
    Ann Med; 1995 Feb; 27(1):107-13. PubMed ID: 7741988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter evaluation of the Elecsys CA 125 II assay.
    Hubl W; Chan DW; Van Ingen HE; Miyachi H; Molina R; Filella X; Pitzel L; Ruibal A; Rymer JC; Bagnard G; Domke I
    Anticancer Res; 1999; 19(4A):2727-33. PubMed ID: 10470230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OVCA (CA125) second generation: technical aspects and serum levels in controls, patients with liver disease, pregnant women and patients with ovarian disease.
    Cioffi M; Fratta M; Gazzerro P; Di Finizio B; Tucci A; Molinari AM
    Tumori; 1997; 83(2):594-8. PubMed ID: 9226027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterologous double-determinant immunoradiometric assay CA 125 II: reliable second-generation immunoassay for determining CA 125 in serum.
    Kenemans P; van Kamp GJ; Oehr P; Verstraeten RA
    Clin Chem; 1993 Dec; 39(12):2509-13. PubMed ID: 8252723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of one first-generation and three second-generation methods for the determination of CA 125.
    Martin MJ; Blockx PP
    Int J Biol Markers; 1996; 11(1):36-9. PubMed ID: 8740640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of four 'second generation' immunoassay systems to determine CA 125 in serum by using a graphical approach to method comparison analysis.
    Koper NP; Thomas CM; Massuger LF; Segers MF; Kiemeney LA; Verbeek AL
    Eur J Clin Chem Clin Biochem; 1997 Aug; 35(8):617-23. PubMed ID: 9298352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of one first and three second generation methods for the determination of CA 125.
    Martin M; Blockx P
    Anticancer Res; 1997; 17(4B):3171-5. PubMed ID: 9329629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No evidence of the hook effect in peritoneal fluid CA 125 measurement using immunoenzymatic second generation assays: comparison with immunoradiometric assays.
    Barbati A; O'Brien TJ; Porpora MG; Orlacchio A; Cosmi EV
    Eur J Obstet Gynecol Reprod Biol; 1995 Sep; 62(1):69-73. PubMed ID: 7493712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter technical and clinical evaluation of a fully automated enzyme immunoassay for CA 125.
    Kenemans P; Bon GG; Kessler AC; Verstraeten AA; van Kamp GJ
    Clin Chem; 1992 Aug; 38(8 Pt 1):1466-71. PubMed ID: 1643716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discordant serum CA 125 values in commercial immunoassays.
    van Kamp GJ; Verstraeten AA; Kenemans P
    Eur J Obstet Gynecol Reprod Biol; 1993 Apr; 49(1-2):99-103. PubMed ID: 8365530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analytical and clinical performance of improved Abbott IMx CA 125 assay: comparison with Abbott CA 125 RIA.
    Thomas CM; Massuger LF; Segers MF; Schijf CP; Doesburg WH; Wobbes T
    Clin Chem; 1995 Feb; 41(2):211-6. PubMed ID: 7874773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Technical evaluation of three second generation CA 125 assays.
    Bonfrer JM; Baan AW; Jansen E; Lentfer D; Kenemans P
    Eur J Clin Chem Clin Biochem; 1994 Mar; 32(3):201-7. PubMed ID: 8031969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and technical evaluation of the ACS:OV serum assay and comparison with three other CA125-detecting assays.
    Davelaar EM; Schutter EM; von Mensdorff-Pouilly S; van Kamp GJ; Verstraeten RA; Kenemans P
    Ann Clin Biochem; 2003 Nov; 40(Pt 6):663-73. PubMed ID: 14629806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of second generation CA 125 assays.
    Cosmi EV; Atlante G; Donadio C; Mariani L; Barbati A
    Eur J Obstet Gynecol Reprod Biol; 1995 Jan; 58(1):73-6. PubMed ID: 7758648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and technical evaluation of ACS BR serum assay of MUC1 gene-derived glycoprotein in breast cancer, and comparison with CA 15-3 assays.
    Bon GG; von Mensdorff-Pouilly S; Kenemans P; van Kamp GJ; Verstraeten RA; Hilgers J; Meijer S; Vermorken JB
    Clin Chem; 1997 Apr; 43(4):585-93. PubMed ID: 9105258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of five immunoassay procedures for the ovarian carcinoma-associated antigenic determinant CA 125 in serum.
    Yedema KA; Thomas CM; Segers MF; Doesburg WH; Kenemans P
    Eur J Obstet Gynecol Reprod Biol; 1992 Dec; 47(3):245-52. PubMed ID: 1294413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CA 19-9 and CA 125 determination by immunoluminometric assay.
    Plebani M; Faggian D; Masiero M; Giacomini A; Burlina A
    J Clin Chem Clin Biochem; 1990 Dec; 28(12):919-21. PubMed ID: 2081962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between Centcor CA 125 and CA 125 II assays.
    Eltabbakh GH; Gupta MK; Belinson JL; Kennedy AW; Webster K; Paraiso MF
    Eur J Gynaecol Oncol; 1996; 17(6):504-6. PubMed ID: 8971528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical evaluation of the Byk LIA-mat CA125 II assay: discussion of a reference value.
    Bonfrer JM; Korse CM; Verstraeten RA; van Kamp GJ; Hart GA; Kenemans P
    Clin Chem; 1997 Mar; 43(3):491-7. PubMed ID: 9068593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of seven immunoassays for the quantification of CA 125 antigen in serum.
    Davelaar EM; van Kamp GJ; Verstraeten RA; Kenemans P
    Clin Chem; 1998 Jul; 44(7):1417-22. PubMed ID: 9665418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.